Company

KaliVir Immunotherapeutics

https://kalivir.com/

Industryclinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs

Funding raised

CompanyRoundDate
KaliVir ImmunotherapeuticsSeries A extension2026-08-19